Journal pre-proof

HIGHLIGHTS

  • who: Preventing Extended-spectrum Beta-lactamases-producing and collaborators from the IncOkayama University and Pharmaceutical Sciences, Okayama, Japan have published the article: Journal Pre-proof, in the Journal: (JOURNAL) of October/18,/2022
  • what: This study was aimed at summarizing the present evidence for the preventive effectiveness of contact precautions for patients with ESBL-E following the systematic scoping review approach. No filters for the study design or language were employed.
  • how: The following data were collected from each study using a standard data collection form in accordance with PRISMA and Cochrane Collaboration . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?